Based on data retrieved from Gene Expression Profiling Interactive Analysis 2 (GEPIA2) database, the high CD320 expression in patients with adrenocortical carcinoma is associated with poorer overall and disease-free survival (Figure 5) [33,34]. Here, CD320 is linked to adrenal cortex carcinoma.